Saturday 17 October 2026
Export ALB’s income statement to Excel — free account
Albemarle Corporation
ALB Basic Materials Specialty Chemicals
Albemarle Corporation’s revenue for fiscal 2025 (year ended December 2025) was $5.1 billion, down 4.37% from fiscal 2024. In the quarter to June 2026, revenue grew 31.1%, EPS grew 2,425.0%, free cash flow grew 708.4% and total debt fell 48.2%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years.
95.48
2.70
−2.75%
Follow ALB
Target Price Range
Analyst price targets
Free accountTen years at a glance Fiscal years to December
| Group | Line | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Trend | 2026e | 2027e | 2028e |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Price, $ | |||||||||||||||
| Price, $ | Low | 45.78 | 86.98 | 71.89 | 58.63 | 48.89 | 133.82 | 169.93 | 112.00 | 71.97 | 49.43 |
Analyst estimates 2026–2028 Powerpack |
|||
| High | 92.24 | 144.99 | 138.67 | 93.14 | 153.48 | 291.48 | 334.55 | 293.01 | 149.61 | 152.08 | |||||
| People | |||||||||||||||
| People | Employees | 5,000 | 5,400 | 5,900 | 6,000 | 5,900 | 6,000 | 7,400 | 9,000 | 8,300 | 7,800 | ||||
| Revenue/emp, $m | 0.54 | 0.57 | 0.57 | 0.60 | 0.53 | 0.55 | 0.99 | 1.07 | 0.65 | 0.66 | |||||
| Income, $m | |||||||||||||||
| Income, $m | Revenue | 2,677 | 3,072 | 3,375 | 3,589 | 3,129 | 3,328 | 7,320 | 9,617 | 5,378 | 5,143 | ||||
| Gross margin, % | 36.24 | 36.01 | 36.07 | 35.04 | 31.80 | 29.99 | 42.00 | 12.33 | 1.16 | 13.00 | |||||
| EBT | 515 | 447 | 795 | 563 | 374 | 134 | 2,433 | 247 | (1,764) | (552) | |||||
| EBT margin, % | 19.25 | 14.54 | 23.55 | 15.68 | 11.94 | 4.02 | 33.24 | 2.57 | (32.80) | (10.74) | |||||
| Net income | 681 | 99 | 739 | 604 | 447 | 200 | 2,815 | 1,671 | (1,135) | (465) | |||||
| Depreciation | 226 | 197 | 201 | 213 | 232 | 254 | 301 | 430 | 589 | 840 | |||||
| Per share, $ | |||||||||||||||
| Per share, $ | Revenue | 23.82 | 27.70 | 31.13 | 33.88 | 29.41 | 28.73 | 62.50 | 81.98 | 45.76 | 43.71 | ||||
| Earnings | 5.73 | 0.49 | 6.40 | 5.03 | 3.53 | 1.07 | 22.97 | 13.41 | (11.20) | (5.76) | |||||
| Cash flow | 6.55 | 2.74 | 5.04 | 6.79 | 7.51 | 2.97 | 16.29 | 11.31 | 5.85 | 10.90 | |||||
| Capex | (1.75) | (2.86) | (6.46) | (7.94) | (7.99) | (8.23) | (10.77) | (18.37) | (14.05) | (4.73) | |||||
| Free cash flow | 4.80 | (0.12) | (1.42) | (1.15) | (0.48) | (5.26) | 5.52 | (7.06) | (8.20) | 6.16 | |||||
| Book value | 35.08 | 34.42 | 34.67 | 38.64 | 42.00 | 50.12 | 69.94 | 82.38 | 86.79 | 83.13 | |||||
| Shares, m | 112 | 111 | 108 | 106 | 106 | 116 | 117 | 117 | 118 | 118 | |||||
| Valuation, × | |||||||||||||||
| Valuation, × | P/E | 15.39 | 274.02 | 12.08 | 14.52 | 41.79 | 214.47 | 9.34 | 10.94 | 0.00 | 0.00 | ||||
| P/S | 3.70 | 4.75 | 2.48 | 2.16 | 5.02 | 8.14 | 3.43 | 1.79 | 1.88 | 3.24 | |||||
| P/B | 2.51 | 3.82 | 2.22 | 1.89 | 3.51 | 4.66 | 3.07 | 1.78 | 1.27 | 2.21 | |||||
| EV/Sales | 3.73 | 4.98 | 2.82 | 2.83 | 5.92 | 8.72 | 3.67 | 2.13 | 2.31 | 3.54 | |||||
| EV/FCF | 18.55 | (1,114.00) | (61.80) | (83.36) | (359.21) | (47.64) | 41.54 | (24.77) | (12.91) | 25.12 | |||||
| Cash, $m | |||||||||||||||
| Cash, $m | Operating cash flow | 736 | 304 | 546 | 719 | 799 | 344 | 1,908 | 1,327 | 688 | 1,282 | ||||
| Capex | (197) | (318) | (700) | (841) | (850) | (954) | (1,262) | (2,155) | (1,651) | (557) | |||||
| Free cash flow | 539 | (14) | (154) | (122) | (52) | (609) | 646 | (828) | (964) | 725 | |||||
| Balance, $m | |||||||||||||||
| Balance, $m | Working capital | 2,167 | 1,277 | 815 | 816 | 404 | 119 | 2,446 | 1,656 | 1,876 | 2,210 | ||||
| Total debt | 2,369 | 1,837 | 1,705 | 3,050 | 3,572 | 2,394 | 3,217 | 4,167 | 3,516 | 3,194 | |||||
| Net debt | 100 | 700 | 1,150 | 2,437 | 2,825 | 1,955 | 1,718 | 3,277 | 2,324 | 1,576 | |||||
| Shareholders’ equity | 3,943 | 3,818 | 3,759 | 4,094 | 4,469 | 5,806 | 8,191 | 9,665 | 10,200 | 9,781 | |||||
| Returns, % | |||||||||||||||
| Returns, % | ROA | 7.25 | 0.69 | 9.05 | 6.11 | 3.70 | 1.15 | 20.35 | 9.33 | (7.55) | (4.11) | ||||
| ROIC | 9.29 | 7.91 | 11.61 | 6.37 | 4.33 | 6.43 | 15.58 | 1.22 | (8.87) | (2.02) | |||||
| ROE | 17.53 | 1.41 | 18.31 | 13.58 | 8.78 | 2.41 | 38.44 | 17.62 | (14.93) | (8.73) | |||||
Negative figures in brackets.
Fiscal years to Dec 2025 · latest quarter Jun 2026
Charts ten years each
Albemarle Corporation vs peers in Specialty Chemicals (Q) = latest quarter vs a year earlier
| Company | Market cap | P/E | Fwd P/E | Revenue growth (Q) | EPS growth (Q) | FCF growth (Q) | Gross margin (Q) | EBIT margin (Q) | Compare |
|---|---|---|---|---|---|---|---|---|---|
| DD DuPont de Nemours, Inc. | $17.8B | 290× | 26.5× | +4.00% (above 0%: growing) | +150.00% (above 0%: growing) | +1,250.00% (above 0%: growing) | 35.13% | 16.38% | Compare |
| RPM RPM International Inc. | $12.8B | 18.4× | 18.3× | +4.82% (above 0%: growing) | +13.75% (above 0%: growing) | +33.14% (above 0%: growing) | 41.25% | 15.99% | Compare |
| ALB Albemarle Corporation | $11.6B | 199× | 14.9× | +31.08% (above 0%: growing) | n/m | +708.43% (above 0%: growing) | 33.86% | 25.98% | |
| SSL Sasol Ltd. | $10.1B | 3.5× | 5.2× | −5.20% (below 0%: shrinking) | +20.86% (above 0%: growing) | +6,912.65% (above 0%: growing) | 31.35% | 0.00% | Compare |
| SOLS Solstice Advanced Materials Inc. | $9.5B | 27.4× | 27.8× | +11.13% (above 0%: growing) | −14.99% (below 0%: shrinking) | +70.83% (above 0%: growing) | 32.23% | 17.16% | Compare |
| ESI Element Solutions Inc. | $8.7B | 47.4× | 33.3× | +56.41% (above 0%: growing) | +60.00% (above 0%: growing) | +29.19% (above 0%: growing) | 34.15% | 11.63% | Compare |
| SQM Sociedad Quimica y Minera S.A. | $8.6B | 11.3× | 12.1× | +138.12% (above 0%: growing) | +381.25% (above 0%: growing) | −63.75% (below 0%: shrinking) | 51.05% | 48.62% | Compare |
| NEU NewMarket Corporation | $8.2B | 18.8× | — (loss-making) | +6.96% (above 0%: growing) | +22.80% (above 0%: growing) | −6.94% (below 0%: shrinking) | 32.45% | 21.91% | Compare |
| WLK Westlake Corporation | $8.1B | — (loss-making) | 24.8× | +10.77% (above 0%: growing) | n/m | +184.09% (above 0%: growing) | 19.93% | 11.13% | Compare |
| Median of peers | $9.1B | 18.8× | 24.8× | +8.87% | +22.80% | +51.99% | 33.30% | 16.19% |
ALB metrics, ten years each
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
Albemarle Corporation (ALB) key facts
- Concern: Albemarle Corporation’s revenue for fiscal 2025 (year ended December 2025) was $5.1 billion, down 4.37% from fiscal 2024.
- Albemarle Corporation (ALB) is a Specialty Chemicals company in the Basic Materials sector, listed on the New York Stock Exchange.
- As of October 16, 2026, ALB traded at $95.48, a market capitalization of $11.6 billion.
- Albemarle Corporation pays an annual dividend of $1.63 per share, a yield of 1.70%.
- Return on equity was −8.73% and debt-to-equity 0.18.
- Its Piotroski F-score is 6 out of 9 and its Altman Z-score is 2.31 (grey zone) for fiscal 2025.